Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Angiogenesis. 2010 Sep 25;13(4):327–335. doi: 10.1007/s10456-010-9189-6

Figure 3.

Figure 3

Dexamethasone suppression of NF-kB activity in HemSCs. Panel A, immunoblotting of HemSCs, treated or untreated with dexamethasone, with anti phosphorylated p65 antibody. Panel B, NF-κB DNA-complexing activity assay. Nuclear extracts of HemSCs, treated or untreated with dexamethasone were assayed for the binding to a NF-κB consensus binding site. Positive and negative controls are detailed in the Results section.